ZyVersa Therapeutics
Pre-clinicalZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases
Founded
2021
Focus
Small Molecules
About
ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases
Funding History
2Total raised: $25M
Series B$15MUndisclosedSep 15, 2022
Series A$10MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2021
LocationWeston, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile